Paisley, UK 3/17/14—Thermo Fisher Scientific has acquired Prionics, an animal health diagnostics company, for an undisclosed amount. Headquartered in Zurich, Switzerland, Prionics’ product line includes more than 50 diagnostics test kits, accessories and biochemicals. Prionics will be part of Thermo’s Life Technologies brand. “Prionics adds a unique blend of expertise and diagnostic solutions to new […]
Cambridge, UK 3/24/14 Cambridge, UK 3/27/14—Gene editing technology firm Horizon Discovery has raised £68.6 million ($113.1 million = £0.61 = $1) in its IPO, resulting in gross proceeds of £40 million ($66 million), prior to listing its shares on the UK’s AIM stock exchange on March 27 (see IBO 2/28/14). The firm started trading at […]
On February 6, the NIH announced the Accelerating Medicines Partnership (AMP), a collaboration among the agency, 10 pharmaceutical companies, seven nonprofit organizations and one trade group, the Pharmaceutical Research and Manufacturers of America (PhRMA). The program will be funded with more than $230 million over five years and will focus on three main areas: Alzheimer’s […]
Based on preliminary figures, US federal budget authority for R&D fell 7.1% in fiscal year 2013 (FY13) to $133.5 billion due to the sequestration. In FY12, it declined 0.4%. Nondefense R&D budget authority fell 3.6% to $61.5 billion, compared to a 4.4% increase in FY12. By budget function, nondefense budget R&D authority for health, natural […]
As a regular feature of our annual forecast issue, IBO selects a firm from our industry as “company of the year.” In designating the company of the year, IBO recognizes an analytical and life science instrument maker that has accomplished technical, operational and financial achievements. Such achievements are a function of strong financial performance, market […]
Thermo and Life The pending merger (see IBO 4/15/13) will create an industry behemoth and creates new challenges for competitors, such as those in the lab distribution market. It also will provide Thermo with a commanding position as a supplier to pharmaceutical and biotechnology companies for both instruments and consumables. The integration process will be […]
R&D spending by US universities declined 3.3% in fiscal year 2012 (FY12) in constant 2005 dollars to $34.6 billion—the first decline in 38 years. Adjusted for inflation, federal government academic R&D spending fell 1.6% to $40,130 million. However, excluding the federal government, R&D spending by US universities rose 4.7% to $25,644 million adjusted for inflation. […]
R&D spending by two thousand of the world’s largest companies grew 6.2% in fiscal 2012 to more than €538.8 billion ($690.8 billion = €0.78 = $1), with 70% of the companies increasing R&D expenditures, according to the recently published The 2012 EU Industrial R&D Investment Scoreboard. This compares to 6.2% growth for these companies in […]
Along with its 2013 Scoreboard, the EU also published a survey of industrial R&D trends. The survey is based on responses from 172 EU Scoreboard companies, which collectively spend €62 billion ($79 billion = €0.78 = $1) on R&D. The respondents expect their R&D expenditures to increase an average of 2.6% from 2013 to 2015. […]
R&D spending by large pharmaceutical companies is stabilizing despite continued restructuring. However, as pharmaceutical companies continue to streamline R&D, resources are shifting to clinical trials. Forced to balance between cost containment and drug development to secure future revenues, companies are prioritizing investments in drugs with the strongest growth potential, especially for therapies that will both […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
